Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I must admit the last 2 times COIN's stock price went up 300%, it was the wacky weed news that drove it up.
Considering the market wide selling ABAT held up rather well today!
I agree.
Also from my experience with business credit, my experience running companies, one would see a pile of very negative credit reports showing unpaid bills past due for a good 6 months, and active collection efforts in the reports, long before any law suits were ever filed. Since the D&B credit report shows no bill payment problems or lawsuits ( http://investorshub.advfn.com/boards/read_msg.aspx?message_id=63465586 ), that pretty much eliminates any possible lawsuits over unpaid vendors bills. I would also like to remind people that most of the drilling and casing costs were covered by escrowed cash from MNLU and Guggenheim before the drilling even started.
Ask yourselves why at this point, would MNLU risk not paying their bills with Guggenheim as a JV partner?
Also, D&B has its own collections department, so they are often the first to hear of slow bill payments!!!
Interesting political- capital investment news for the green economy. No direct, immediate impact on MVTG, but a sign that we are still heading in the right direction.
http://news.ino.com/headlines/?newsid=68978686546880
May 17 SEC 10-Q/A shows only 52,774,743 shares outstanding!!!!!
Looking at the volume today, it looks like they bought enough cheap shares to cover their short sale of 100,000 shares last week at .18 that IMHO led to the recent MM raid right after a 100,000 share buy at .18/share last week, sad to see how easily the MM's can manipulate the TTEG share price to cover their mistakes.
After stealing nearly about 45,000 shares by pushing the price down to .12 this morning, we now have a large volume support price at .14 already, with ask back at .15
If you want shares buy them now, as they are likely to be back at .18 and moving up again shortly, IMHO.
If anyone knows something I missed (like in the last 10-Q?), please fill me in, as this looks like a great buy this morning to me.
The 40 million dollar line of credit was paid off, and ended last year, the one with Guggenheim. But rest assured, if needed Guggenheim would lend their current MNLU, BV, BP well#1 partner money under a new credit line, IF they needed it.
For now, from what Gerry (new director, IR guy) has told me and others who bothered to call him and ask, they are borrowing cash (loans only) from rich investors to pay the current bills, and my guess is they are being real picky where the loan cash comes from at this time!!!!! I got the impression the loans were unsecured since secured loans required SEC filings, and UCC filings!!!!
But the next 10-Q which should be out by my estimates, by Tuesday next week, and should answer all these questions!!!! Gerry told me last week they are having no problem paying the bills, and the rumors could get certain rumor spreaders into legal trouble under the new rules!!!!!
Anyway, I guess my post last week, about rumors, of rumors, turned out not to be a rumor after all, but lies about rumors, LOL!!!!
I got word of this last week by email (I will not mention names), and I spoke with Gerry (IR, and the new MNLU director) that day, after I got the email, and he laughed. I mentioned here last week that these baseless rumors were circulating in back channels, and that they were not true, and that they would likely surface here soon, and not to believe them.
At this moment I suspect some people are stuck with large shorts, and trying to scare people into selling, by spreading lies, to cover shorts and buy cheap shares. My best advice is do not trade based on rumors (unless you are the one spreading them, LOL!)
Shorts did some covering on Friday, but there are still a good number of them left:
http://shortsqueeze.com/?symbol=mnlu&submit=Short+Quote%99
If the accusations of lawsuits were true, where is the public filing information? Do a Google search, you will find nothing.
If you are really concerned about this rumor, just order a D&B credit report on MNLU:
https://smallbusiness.dnb.com/ePlatform/servlet/ReportSelectionCmd?dunsNumber=0&busName=MAINLAND%20RESOURCES%2C%20INC.&searchType=&storeId=10001&catalogId=70001&productId=0&address=21%20WATERWAY%20AVE%20STE%20300&city=THE%20WOODLANDS&state=TX&zip=773803099&country=US
I agree with Shaleonyou's post earlier today, and found the same lack of any proof that they have been sued for not paying bills.
Mine (Fidelity Brokerage) is showing it as MNLU again at .30 to .33
Look here for current quotes:
http://www.otcmarkets.com/stock/MNLU/quote
If anyone is really concerned about this credit and unpaid bills rumor, just order a D&B credit report on MNLU:
https://smallbusiness.dnb.com/ePlatform/servlet/ReportSelectionCmd?dunsNumber=0&busName=MAINLAND%20RESOURCES%2C%20INC.&searchType=&storeId=10001&catalogId=70001&productId=0&address=21%20WATERWAY%20AVE%20STE%20300&city=THE%20WOODLANDS&state=TX&zip=773803099&country=US
I saw something over the weekend that showed that MNLU was converted to MNLUE (for 20 days) for being late with their 10-Q, but they were in fact not late, and the OTCBB change was an error, that has been corrected today. The OTCBB mistake had to do with market value or equity, and in MNLU's case they actually had, and have until the end of May to file a timely 10-Q.
Brokers are sometimes a day late posting the correct data, and value when a symbol change takes place. I use Fidelity, and it already has been updated to MNLU with the correct number of shares and value, so I would not worry. If you want to trade shares on a day like this, and and your E-system is not working properly (not updated correctly yet), you need to call your broker to make a phone order. I think your last post said yours finally updated OK, but I thought I would post this for all readers.
Was this one a Reverse merger to get listed on the US exchanges also?
Yep. Near as I can tell the entire business plan, financial model for the original NJ plant must have been seriously flawed, as well as the licensed technology for it.
I think the only reason they survived was the buying of the California facility and its alternate IP properties, and the market name and fertilizer sales they had created. The recent Terra merger gave them the illusion of stock holders equity (which is all it is, an illusion, unless Terra gets off their rear end and closes some deals with cash up front!). The company is currently top heavy on bloated exec salary IMHO, based on their poor performance to date, and they have reverted to taking on toxic convertible stock debt to pay the bills. And they just set up toxic take over pills (nice fat severance contracts) for the chief execs, in case they get canned when the new share conversions show up from the toxic financing.
I once had very high hopes and expectations for this company. It is a shame stock holders can not sue CEO's for being incompetent!
http://www.genengnews.com/gen-news-highlights/cytrx-sells-molecular-chaperone-assets-to-orphazyme-in-deal-worth-120m/81245156/
CytRx has sold worldwide rights to its molecular chaperone assets to Danish firm Orphazyme, in a deal that includes an up-front fee and potentially another $120 million in milestones, plus future sales royalties. CytRx says the sale is the last stage in its move to divest its noncore assets and focus on its clinical-stage oncology pipeline. “This could be a game-changing transaction for CytRx with an ultimate potential value that exceeds our current market capitalization,” remarks Steven A. Kriegsman, president and CEO. "This transaction provides us with additional resources to focus on our highly promising oncology drug candidates.”
The assets acquired by Orphazyme include three orally administered molecular chaperone amplifiers—arimoclomol, iroxanadine, and bimoclomol—which together have been evaluated in 13 Phase I and six Phase II clinical trials. CytRx molecular chaperone amplifiers are believed to act by co-induction of the stress response, such that rather than activating the stress response directly, they instead amplify the production of molecular chaperone proteins that are already activated by disease-induced cellular stress.
Orphazyme was established in 2009 to develop molecular chaperone therapies for treating rare genetic lysosomal diseases. The firm’s scientific strategy hinges on the lysosome-protective and stabilizing effect of heat shock proteins (HSPs). Its existing lead program, Orph-001, is a recombinant version of human HSP70, which is currently being evaluated in vivo in animal models.
”We believe that CytRx’ molecular chaperone technology can be used to revert lysosomal pathology through the induction of heat shock proteins, such as HSP70, and thus can be applied to develop new treatments for these diseases,” comments Orphazyme CEO Anders Hinsby, Ph.D.
CytRx, meanwhile, will continue to focus on its core oncology pipeline, which includes three clincial-stage candidates: bafetinib, tamibarotene, and INNO-206. Bafetinib is an orally available, dual Bcr-Abl and Lyn-kinase inhibitor, originally developed by the Nippon Shinyaku, to overcome the limitations of Gleevec and second-line tyrosine kinase inhibitors in resistant chronic myelogenous leukemia. The drug is in Phase II trials against B-cell chronic lymphocytic leukemia and advanced prostate cancer, and it is in Phase I evaluation against brain cancer.
Tamibarotene is an orally available, synthetic retinoid compound designed to avoid toxic side effects by binding to its molecular target more selectively than all transretinoic acid (ATRA), the current first-line treatment for APL, CytRx claims. It has completed Phase I studies in non-small cell lung cancer, and is undergoing a pivotal Phase II study in acute promyelocytic leukemia (APL). Phase I combination studies for the APL indication are also in progress. CytRx retains an option to expand its existing licenses for the use of tamibarotene for other oncology indications, including multiple myeloma, myelodysplastic syndrome, and certain solid tumors in the U.S., and multiple myeloma, myelodysplastic syndromes, and solid tumors other than hepatocellular carcinoma in Europe.
INNO-206 is a prodrug derivative of the commonly prescribed chemotherapeutic agent doxorubicin. CytRx holds the exclusive worldwide rights to the drug, which is designed to reduce adverse events by controlling drug release and preferentially targeting tumors. INNO-206 has completed Phase I evaluation against pancreatic cancer and soft tissue sarcomas.
After 34 years Voyager 1 and 2 are still working!!! Now leaving the solar system!
The spacecraft are powered by a radioisotope thermoelectric generator, in essence a nuclear battery. Pellets of plutonium release heat through natural decay and are converted into electricity using a series of thermocouples. It is a safe, reliable and long lasting power source expected to be finally depleted somewhere around 2025. Voyager's thrusters are fueled by hydrazine and there is enough on board to last another 60 years as fuel is only used to reorient the spacecraft. It uses about 1.6 grams per day.
Voyager carries various scientific instruments along with three computers that share just 68 KB of memory. Engineers developed a self repairing, programmable command processor with multiple modules that are able to determine errors by comparing past data.
The last time we checked on the Voyager 1 & 2 they were hurtling towards the edge of the solar system at over 37,000 mph (60,000 km/h). The car-sized spacecraft are now and incredible 11 billion miles (17 billion km) and 8 billion miles (14 billion km) from Earth respectively - they are the longest continuously operated spacecraft in deep space and, having traveled further than any man-made object, they will soon become the first to enter the realm of interstellar space.
Built by NASA's Jet Propulsion Laboratory in Pasadena, California, Voyager 2 was launched on Aug 20, 1977, closely followed by Voyager 1 on Sept 5. It was a special year because there was a rare planetary alignment of the outer planets, which meant the spacecraft would be able to visit all four giant gas planets; Jupiter, Saturn, Uranus and Neptune.
The Voyager twins' primary five year mission was to explore Jupiter (which was reached in 1979) and Saturn (1980). The spacecraft captured images of the planets, their larger moons and Saturn's rings, making some amazing discoveries. Jupiter's Red Spot was found to be a massive hurricane three times the diameter of Earth and just one of many huge storms on the planet. Saturn's rings were revealed to be made of a mish mash of icy particles - some as large as a house. Io, one of Jupiter's moons, was observed to have eight active volcanoes, where previously volcanic eruptions were only known on Earth.
Voyager 2, propelled further by Jupiter and Saturn's gravity, continued to Uranus in 1986 and Neptune in 1989. Breathtakingly close up pictures were taken of the planets, their moons and the system of rings and magnetic fields surrounding each. Notable discoveries included the fact that Uranus spins on a horizontal axis. Neptune the most remote giant planet has the fastest winds in the solar system that travel at over 1,200 mph (2,000 kph). Like Jupiter, it has a Great Dark Spot of its own, a giant storm about the size of Earth. Triton, a moon of Neptune is the coldest measured object in the Solar System. It has a surface temperature of -390°F (-235°C) with geysers spewing nitrogen gas into the atmosphere.
The Voyager spacecraft rewrote the textbooks on the four gas giants revealing the complexity and diversity of our solar system. On its way out of our solar system, Voyager 1 was asked to look back and take more photograph before the cameras were turned off. The "Pale Blue Dot" photograph was taken from a record distance of more than four billion miles from Earth and is part of the resulting is 60 frame mosaic of the solar system. In the photo, the Earth appears as a tiny dot 0.12 pixels in size, giving us a mind-boggling reminder of just how small we are in the vastness of space.
More on the history and story!!!!
http://www.gizmag.com/voyager-spacecraft-interstellar-space/18557/?utm_source=Gizmag+Subscribers&utm_campaign=7dae3cd16b-UA-2235360-4&utm_medium=email
The spacecraft are still functioning and thriving after more than 30 years. Robust, durable and built from 1970s components, the transistors are still functioning today. They have exceeded their design specifications and the loftiest dreams of their makers ... and despite having already made an amazing contribution to our civilization, many great discoveries are still to come.
Voyager 1 is on a trajectory to reach star AC+79 in about 40000 years. Voyager 2 is on its way to the vicinity of star Sirius, a mere 296,000 years away.
Thanks for the reminder!!!!
I have been researching the internet on the new MNLU director, Gerry Jardine, et., al.
http://finance.alphatrade.com/story/2011-05-16/CCN/201105160801CCNMATHWCANADAPR_0696988001.html
http://www.mercergoldcorp.com/index.php?option=com_content&view=article&id=104&Itemid=59&lang=en
http://incakolanews.blogspot.com/2011/05/changes-at-scam-mercer-gold-mrgpob.html
Note that the last above predates the Gerry, it relates the entire staff that just left. Also note that Rahim Jivraj was the CEO, and a director (Gerry replaced him as a director).
http://incakolanews.blogspot.com/2011/03/mercer-gold-mrgpob-does-what-all-scams.html
http://otcpicks.com/Mercer-Gold-Corp.htm
Long term, yes I am. For now it is very volatile!!! News has been slow lately.
Agreed. If I had the cash I would be adding here.
LOL, my BE is $1.27
I started with shares in 09 at about .40
But I started adding recently at the lows
Interesting that Gerry is replacing the same guy in both companies. Gerry is also the IR guy I have talked with twice now the last 4-5 weeks, We talked for a good 30-45 minutes both times. He is a straight shooter. I look forwarding to meeting him here at the next stock holders meeting.
If I had not talked with Gerry for so long already (feel like I know the guy real well already) I would be a little worried about PR showing him replacing the same guy in that Gold company which at first look only shows a one month trading stock price for a gold mining company with a 4 million dollar market cap listed in Canada and mining (or planning to mine?) in Columbia? Also looks like they cleaned house of the BOD in that Gold mining company (5 replaced at once?)? But since Gerry just joined that company, not really fair to say anything about him versus that companies past.
Time for DD homework this weekend folks?
I think he is just dog-ing us!
LOL
I think this one is a serious sleeper. Just takes a long term perspective. We have regular good news, occasional surprise profitable quarters, management that knows how to buy and sell promising drug tech and drug tech companies (at a profit), very promising drugs in the pipeline, a strong rising support line for low risk buys and additions (currently at about .80 to .82), marketable shares in ANX that should triple in value later this year (I also have shares in ANX), and two drug companies now footing the bill to move two previously shelved for funding CYTR products along the pipeline at their expense, with rewards for CYTR if and when they pass periodic stages of testing toward FDA approval. CYTR has plenty of cash, survived the 08-09 crash and the recent trial news on main line drugs as been astounding!
The way that quote reads, I can buy 5000 shares right now for .31 and sell them for .32 immediately! Does that make sense to anyone here?
I would buy any cheap shares that get tossed our way before May 30th!!!!
Other topic, I have lost all faith in the quotations systems this week. I have seen crazy, impossible action and quotes on TTEG and MNLU, and AEXP this week. Fidelity has shown min bids of .20 on TTEG since noon yesterday, while the pink sheets and MM's walked the price down to .15, after 80% of the days volume was a 100,000 share buy at .18 at noon yesterday. That 100,000 share buy at the ask was 80% of last weeks volume, and 60% of this weeks volume. All trades since then have been at .16 to .15, while Fidelity showed a .20 bid the entire time. Looks to me like an MM or somebody filled a large order and now they are forcing the price down to get shares to fill the short sale by the MM or their automated system. Now MNLUE is showing this!
http://www.otcmarkets.com/stock/MNLUE/quote
Showing a huge volume bid at .32 since yesterday, while shares sold at .285 today? RAJA bid: 0.32/share for 90000 shares
since 05/19
And ask shows: o
VERT 0.31 5000 12:15
HDSN 0.32 5000 11:41
NITE 0.33 29750 12:17
ETMM 0.39 52900 05/19
Are the bid systems now displaying all or none orders, or limit orders (which can be bypassed? They are not required to post them under the new rules. Are the MM's ignoring the bids?
There was a similar rigged raid on AEXP shares once last week and once earlier this week, where the quote system was gamed to grab a bunch of cheap shares at .05 last week and .6 this week.
I am not worried about the late report. Monday I was told we could expect a report in about 2 weeks, that was 4 days ago, so maybe May 30-31 we will see it. I did not realize at the time they working on a soon to be late report. Slightly, late reports are not that unusual.
BV site ( BF#1) does not flood, only the access road according to MNLU staff. I asked them earlier this week. The well site is and will stay high and dry even with the record flood.
Insiders are on a buying a spree!!!!!!!!!!!!!!!!
Another 8,000 shares grabbed by a director!
http://secwatch.com/bcon/4/insider-trading/2011/5/19/8810340?s=alert
OK, now the ask is only .16, after 80% of the shares traded today (100,000 shares) were a buy at the ask of .18, so I am now calling "Shenanigans", Some one is deliberately walking the price down hard after that huge buy! Only question is who, why, and how?
Something very suspicious is going on here today. Somebody bought 100,000 shares at .18, and now the MMs have walked the bid and ask down to .15/.16 ??? On the OTCBB Pink sheets quote, and shares just traded at .15/share when Fidelity was showing the bid at .20 share!!!!!
Somebody is fixing the books here today!!!! SEC are you listening?
I think an MM is stuck now trying to cover the shares they sold at .18 that they did not have!!!! But what is so puzzling is how Fidelity can show bids at .20 and OTCBB pink sheets is stuck showing a 2 hr old data set (.165/.17 bid/ask) that suddenly drops to .15 bid, .16 ask?
All I know is was not one of them. I waiting for the cheap shares at 1.22 to make my first dip in the pool, while others were throwing money at it in the $3-4 dollar area.
I will add at .60 and .30 if we ever get there!
Fidelity shows that somebody just bought 100,000 shares at .18!!!!!
And it wasn't me!!!!
What is odd, is that the pink sheets is not updating the bid and ask today on TTEG.
Fidelity shows the bid at .20 already, but pink sheets still shows 5000 shares offer at .17
I think OTCBB pinks sheets quote system is having problems again this week!
TTEG is on sale again, ask at .17, but not many shares for sale, not even at .20
Time to stock up if you have not already done so. Spread is only .005/share!
Be sure to watch the max pain options monthly numbers. A lot of the stock price in EK is all about options trading by the big boys, and tomorrow is OPEX.
The Hedge newsletter I get said there was unusual PUT activity on EK this week!
Could they be getting the bad news out of the way, and setting a trap for shorts?
Great Caesars Ghost!!!!
There are several new distributors, and even what looks like a private label seller on line now!!!!
I did not see this the last time I looked!!! PROGRESS indeed!!!!
http://www.google.com/search?q=intact+digest+supplements&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a
http://www.lef.org/Vitamins-Supplements/Item01021/Intact-Digest.html
http://www.lifeextensionvitamins.com/indiliex.html
http://health.blog107.com/2011/04/02/natural-health-supplements-provider-intact-nutrition-suggests-intact-digest-4/
http://www.evitamins4u.com/intactdigest?page_566308336=1
I saw the same strong support for 6-9 months at .30/share, .20/share, and .12/share while they sold new shares to accredited investors out the back door at 66% discounts. The Investors were no doubt selling old shares at retail while buying new shares at 66% discount to retail. Every time the SEC reports came out showing huge dilution at 66% discount the retail price fell hard. I expect they will sell new shares after the R/S at $1 or less, while retail is paying $2- $3. Current issued price for new shares is and has been .02 to .025/share so 40X.02 = .80/share!!!!!!
All the proof in the last 2.5 years of SEC reports!!!
I have bought more shares twice this week, today at $1.22/share.
Form 4 showed up at the SEC today on BCON, with insider buying, a director bought 8000 shares at $1.24 this week!
I was going to wait for a lower price to add more but the Form 4 today was enough to convince me this may be a bottom here.
It is 40 for one, not 1 for 40. 40 shares will turn into one share, and the price of the one share will 40 x the price of the old penny shares, so .065 x 40 = 2.60 per new share. The number of shares will outstanding will drop by 40 times.
The stock price usually collapses after such a split, as shorts like to short dollar stocks right after a reverse split.
Do you people ever read the SEC filings?
http://www.sec.gov/Archives/edgar/data/1413891/000106299311001594/form10q.htm
The latest published official data is there, from Friday last week.